Objective """The World Health Organization (WHO) in its “Global status report on noncommunicable diseases 2014” shows that the impact of noncommunicable diseases (NCDs), also known as chronic diseases, is steadily growing. NCDs are the leading cause of death globally (68% of all deaths in 2012). The 4 main types of NCDs are cardiovascular (CVD) diseases (like cerebrovascular accidents or strokes and heart attacks), cancers, chronic respiratory diseases and diabetes. Cardiovascular diseases account for most NCD deaths (17.5 million people annually), followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million).This proposal addresses the prevention and early diagnosis of 2 types of NCDs, Cardiovascular (CVD) diseases and diabetes, by providing health professionals a tool for automatic quantification of parameters of the retina and automatic detection of lesions of the retina, with capacity for prevention and/or early detection of various diseases.ULMA Embedded Solutions (UES) has developed a non-invasive and cost-effective tool for Automatic evaluation of Retinal Imaging Biomarkers (ARIB), which can be used in public health interventions delivered through a primary health-care approach to strengthen early detection and timely treatment of various diseases. Evidence shows that such interventions are excellent economic investments because, if applied to patients early, can reduce the need for more expensive treatment. """ Fields of science medical and health sciencesclinical medicineendocrinologydiabetesmedical and health scienceshealth sciencesinfectious diseasesRNA virusescoronavirusesmedical and health sciencesclinical medicinecardiologycardiovascular diseasesmedical and health sciencesclinical medicineophthalmologyretinopathymedical and health sciencesbasic medicineneurologystroke Programme(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) ICT-37-2015-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2015 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ULMA MEDICAL TECHNOLOGIES S COOP Net EU contribution € 50 000,00 Address GARAGALTZA AUZOA 51 20560 Onati Spain See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Noreste País Vasco Gipuzkoa Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00